Course Faculty and Invited Speakers

Dr. Smaragda Diamanti 

European University Cyprus 

Dr. Diamanti is an associate professor of oral medicine and oral pathology at the School of Dentistry at European University Cyprus and a major general in the Hellenic Air Force. She also serves as vice chair of the School of Dentistry, a position she has held since 2022.

Diamanti graduated from the School of Dentistry at the National and Kapodistrian University of Athens, where she specialized in oral medicine and earned her PhD in 2016. She trained in aerospace medicine at the U.S. Air Force School of Aerospace Medicine at Brooks Air Force Base in Texas and received additional training in the management of vesiculobullous mucocutaneous diseases at Federico II University of Naples.

From 2007 to 2020, Diamanti served as director of the Department of Oral Medicine at the 251 Hellenic Air Force General Hospital. She concurrently served as director of the hospital’s Dental Sector from 2015 to 2019. She joined European University Cyprus as an assistant professor of oral medicine and oral pathology in 2019 and was appointed associate professor in 2025.

Diamanti has received honorary distinctions and medals from the Hellenic Air Force General Staff. She has delivered lectures and presentations at national and international conferences and contributed to Greek and international journals and book chapters.

Dr. Robert Hadad

Dana-Farber Cancer Institute

Dr. Robert I. Haddad, MD, is the McGraw Chair in Head and Neck Oncology, chief of the Division of Head and Neck Oncology, and an institute physician at Dana-Farber Cancer Institute. He is also a professor of medicine at Harvard Medical School and leads a multidisciplinary head and neck cancer program at Dana-Farber.

Haddad’s clinical and translational research focuses on locally advanced and recurrent or metastatic head and neck cancer, including systemic therapies, multimodality treatment strategies, and biomarker-driven approaches. He has held leading roles in international clinical trials, including TAX 324, which established TPF induction chemotherapy; CheckMate 141, which helped introduce immunotherapy for recurrent or metastatic disease; and KEYNOTE-689, a phase 3 trial demonstrating the benefit of perioperative pembrolizumab for resectable, locally advanced head and neck cancer.

Dr. Amanda Psyrri

Attikon University Hospital

Dr. Ahmed Sultan

University of Maryland School of Dentistry

Dr. Alessandro Villa

Herbert Wertheim Cancer Institute at Baptist Health South Florida

Dr. Alessandro Villa is chief of Oral Medicine, Oral Oncology, and Dentistry at the Herbert Wertheim Cancer Institute at Baptist Health South Florida and a professor at Florida International University’s Herbert Wertheim College of Medicine.

Villa’s clinical and academic work focuses on diagnosing and managing complex oral diseases in patients with cancer, including oral mucositis, salivary gland dysfunction, oral potentially malignant disorders, and medication-related osteonecrosis of the jaw. He has led and participated in clinical trials and multidisciplinary research initiatives aimed at improving oral health and quality of life for patients with cancer.

Villa is president of the International Society of Oral Oncology and president-elect of the American Academy of Oral Medicine. He previously held academic and clinical leadership positions at Harvard School of Dental Medicine, Brigham and Women’s Hospital, and the University of California, San Francisco. He has authored more than 200 peer-reviewed publications and is an international speaker and educator.

Dr. Sook-Bin Woo 

Dana-Farber Cancer Institute

Dr. Sook-Bin Woo is professor emerita at Harvard School of Dental Medicine. She completed training in oral pathology at Indiana University School of Dentistry and Harvard School of Dental Medicine, general and head and neck pathology at Long Island Jewish Medical Center in New York, and oral medicine at Harvard School of Dental Medicine. She is board-certified in oral and maxillofacial pathology and oral medicine.

Woo’s teaching, mentoring, and research activities span Harvard School of Dental Medicine and the Oral Medicine Residency Program at Brigham and Women’s Hospital. She lectures nationally and internationally on oral precancer and the diagnosis and management of oral inflammatory diseases.

Her honors include a National Research Service Award from the National Institutes of Health, a Career Development Award from the American Cancer Society, and the Distinguished Senior Faculty Award from Harvard School of Dental Medicine. She has authored more than 200 peer-reviewed publications and book chapters. The fourth edition of her textbook, Oral Pathology, is in progress.